809 Pou4f1 Promotes Braf Inhibitor Resistance by Reactivating Mapk Signaling Pathway in Melanoma

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.885
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Correction: ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma

Cancer Discovery
Oncology
2019English

A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-mutant Melanoma

Cancer Research
Cancer ResearchOncology
2020English

Melanocytic Signaling Promotes Resistance to MAPK Inhibition

Cancer Discovery
Oncology
2013English

Grp94-Specific Monoclonal Antibody to Counteract BRAF Inhibitor Resistance in BRAFV600E Melanoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors

Cancer Discovery
Oncology
2017English

Inhibition of YAP Function Overcomes BRAF Inhibitor Resistance in Melanoma Cancer Stem Cells

Oncotarget
Oncology
2017English

Inactivating BRAF Mutations Modulate RAS–MAPK Signaling

Cancer Discovery
Oncology
2017English

PEA15 Promotes Liver Metastasis of Colorectal Cancer by Upregulating the ERK/MAPK Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy